COMMERZBANK AKTIENGESELLSCHAFT /FI - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2020$1,729,000
+626.5%
75,048
+824.4%
0.11%
+5200.0%
Q4 2019$238,000
-98.7%
8,119
-98.9%
0.00%
-98.7%
Q3 2019$18,949,000
+65.2%
709,427
+58.1%
0.15%
+90.1%
Q2 2019$11,469,000
+56.6%
448,711
+37.3%
0.08%
+9.5%
Q1 2019$7,326,000
-3.2%
326,769
-9.0%
0.07%
-9.8%
Q4 2018$7,571,000
-27.5%
358,979
-36.4%
0.08%
-17.2%
Q3 2018$10,446,000
+7.4%
564,051
+29.4%
0.10%0.0%
Q2 2018$9,722,000
-21.4%
435,749
-22.6%
0.10%
-28.3%
Q1 2018$12,373,000
-11.9%
562,927
-6.9%
0.14%
-20.7%
Q4 2017$14,051,000
-28.9%
604,583
-29.8%
0.17%
-33.1%
Q3 2017$19,769,000
-18.5%
861,033
-21.6%
0.26%
-36.1%
Q2 2017$24,259,000
+41.6%
1,098,709
+46.3%
0.41%
+60.2%
Q1 2017$17,132,000
-24.9%
751,070
-31.1%
0.25%
-24.2%
Q4 2016$22,804,000
+50.9%
1,090,036
+90.6%
0.34%
+37.3%
Q3 2016$15,115,000
+66.9%
571,883
+74.9%
0.24%
+300.0%
Q2 2016$9,059,000326,9040.06%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders